Charlotte Dupuis

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.7K citations · Full text

Medicine, Oncology, Pharmacology +11

High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy

Charlotte Dupuis, Cédric Mercier, Chenguang Yang et al. · Anti-Cancer Drugs · 2008 · 55 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation

Cédric Mercier, Caroline Raynal, Laëtitia Dahan et al. · Pharmacogenetics and Genomics · 2007 · 54 citations

Medicine, Oncology, Pharmacology +17

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients

François Bécher, Joseph Ciccolini, D Imbs et al. · Scientific Reports · 2017 · 54 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile

Cédric Mercier, Charlotte Dupuis, Aurore Blesius et al. · Cancer Chemotherapy and Pharmacology · 2008 · 43 citations

Medicine, Pharmacokinetics, Pharmacology +7